Showing 20 of 10178 recruiting trials
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network
Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems
Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance
👨⚕️ Anne-Laure Castell, MD, Centre de Recherche en Nutrition Humaine Rhône-Alpes📍 1 site📅 Started Nov 2025View details ↗
ESP vs SPSIP Block in VATS Analgesia
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
RecruitingNCT07084480 ↗
Giant Cell Arteritis - Ways to Precision Medicine
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Actinium Therapy for Late-stage Aggressive Sarcomas
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
👨⚕️ Michail S Lionakis, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Nov 2025View details ↗
Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
👨⚕️ Joshua D Palmer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Nov 2025View details ↗
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
RecruitingNCT07235709 ↗
Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study
Basic Body Awareness Therapy Added to Scoliosis-Specific Exercise in Adolescents With Scoliosis
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →